| Outcome Measures: |
Primary: Change in serum ketone levels after treatment, Change in serum ketone levels before and after treatment with either dapagliflozin or sitagliptin for 24 weeks, 24 weeks | Secondary: Change in fasting glucose, Change in fasting plasma glucose before and after treatment with either dapagliflozin or sitagliptin for 24 weeks, 24 weeks|Change in glycated haemoglobin, Change in glycated haemoglobin before and after treatment with either dapagliflozin or sitagliptin for 24 weeks, 24 weeks|Change in body weight, Change in body weight before and after treatment with either dapagliflozin or sitagliptin for 24 weeks, 24 weeks|Change in blood pressure, Change in systolic and diastolic blood pressure before and after treatment with either dapagliflozin or sitagliptin for 24 weeks, 24 weeks|Change in fasting lipid, Change in fasting lipid before and after treatment with either dapagliflozin or sitagliptin for 24 weeks, 24 weeks|Change in free fatty acid levels, Change in free fatty acid levels before and after treatment with either dapagliflozin or sitagliptin for 24 weeks, 24 weeks|Change in fasting glucagon levels, Change in fasting glucagon levels before and after treatment with either dapagliflozin or sitagliptin for 24 weeks, 24 weeks|Change in homeostasis model assessment 2 steady-state beta-cell function, Change in homeostasis model assessment 2 steady-state beta-cell function before and after treatment with either dapagliflozin or sitagliptin for 24 weeks, 24 weeks
|
